| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 3, 2026 | PharmaTher targets new U.S. peptide pathway with 3D printed colon-release tablets | PharmaTher Holdings is building a range of 3D printed peptide products for a new U.S. compounding pathway. The first two are oral tablets of KPV and BPC-157 designed to release their dose in the colon. It is timed to the U.S. Department of ... |
| Oct 19, 2026 | OncoC4 Announces NMPA Acceptance of Two IND Applications for Cesalatamig Combination Studies with ADCs and Pan-RAS Inhibitors | — New Studies Expand Cesalatamig into Biomarker-driven Precision
Immuno-oncology Strategies
— Cesalatamig is Also Being Evaluated in Ongoing Phase 2 Studies in
the United States and in China
ROCKVILLE, Md. , Oct. 19, 2026 /PRNewswire/ -- On... |
| Oct 9, 2026 | Everest Medicines Appoints Two Veteran mRNA Cancer Vaccine Scientists to Advance Global Clinical Development | Lakshmi Srinivasan, PhD, former Executive Director and Head of Oncology Translational Medicine at Moderna, and Brandon Coder, PhD, former Research & Early Translational Lead, Cancer Vaccines at Moderna, join Everest Medicines
Appointmen... |
| Oct 6, 2026 | Sensible Biotechnologies Raises $47 Million To Advance Naturally Modified mRNA Platform | Sensible Biotechnologies has secured $47 million in financing to advance and scale its platform for naturally modified mRNA medicines. The financing includes a Series A led by Oxford Science Enterprises and up to $20 million of non-dilutive... |
| Sep 16, 2026 | OncoC4 Receives FDA Fast Track Designation for Cesalatamig, an Investigational PD-1/VEGF Bispecific Antibody | Cesalatamig is Currently Being Evaluated in Phase 1/2 Studies in the United States (NCT06635785) and in China (CTR20253261)
Fast Track Designation Supports Expedited Development of Cesalatamig for Non-small Cell Lung Cancer (NSCLC) that Pro... |
| Sep 3, 2026 | This vaccine reduces risk of melanoma coming back. Can it work for other cancers? | Getting your Trinity Audio player ready...
Intismeran Autogene, a vaccine that treats melanoma, a deadly type of skin cancer, has made headlines worldwide. Recently reported results indicate that the personalized medication, taken in combin... |
| Aug 28, 2026 | China's DualityBio Rises After Forging USD1 Billion Cancer Drug Tie-Up With Roche Unit | (Yicai) Aug. 28 -- Shares of Duality Biotherapeutics rose after it said it has agreed to co‑develop next‑generation antibody‑drug conjugates for multiple oncology indications with Genentech, a subsidiary of Switzerland's Roche, based o... |
| Aug 21, 2026 | CNA Explains: What we know about the Moderna, Merck breakthrough cancer vaccine | Listen
5 min
New: You can now listen to articles.
This audio is generated by an AI tool.
Drugmakers Moderna and Merck have scored a breakthrough with a personalised cancer vaccine that doctors hope could eventually work against many types o... |
| Aug 4, 2026 | BioNTech Slashes 2026 Revenue Guidance by €700M as COVID Vaccine Sales Crater | By Brandi Henkel
Published: Aug 04 2026, 2:28 PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| Dec 4, 2025 | Why Big Pharma Hasn’t Fully Adopted 3D Printing—Yet: Inside Triastek’s Push to Modernize Drug Manufacturing | In pharmaceutical manufacturing, tablets have long been produced through standardized processes that leave little room for fine-tuning how a drug behaves once ingested. Chinese pharmaceutical technology company Triastek is challenging that ... |
| Nov 1, 2025 | Helex Secures $3.5M to Revolutionize Kidney Disease Gene Therapy | Helex, a pioneering biotech firm, secured $3.5 million in seed funding. This investment propels gene therapies for chronic kidney diseases. The company targets Autosomal Dominant Polycystic Kidney Disease (ADPKD). Its innovative platform co... |
| Oct 30, 2025 | Helex Raises $3.5M in Seed Funding | Helex, a NYC-based therapeutics company developing a new class of targeted medicines for genetic kidney diseases, raised $3.5m in Seed funding.
The round was led by pi Ventures, with participation from Bluehill Capital, SOSV, and a global s... |
| Oct 27, 2025 | China's NMPA Grants Breakthrough Therapy Designation for Anti-CTLA-4 Antibody Candidate Gotistobart (BNT316/ONC-392) | Designation granted for gotistobart (BNT316/ONC392) for the treatment of patients with squamous non-small cell lung cancer (sqNSCLC), an aggressive subtype of lung cancer
Breakthrough Therapy designation will allow for an expedited developm... |
| Oct 24, 2025 | Pfizer and BioNTech Receive Health Sciences Authority Approval for SARS-CoV-2 Sublineage LP.8.1-Adapted Monovalent COVID-19 Vaccine in Singapore | The updated COVID-19 vaccine is expected to be available in Singapore at selected polyclinics and private general practitioner (GP) clinics in October 2025 for individuals 6 months of age and older.
SINGAPORE, Oct. 24, 2025 /PRNewswire/ -- ... |
| Oct 16, 2025 | Merz calls for pan-European stock exchange | Friedrich Merz has called for the creation of a pan-European stock exchange in a move that would help it compete with Asian and US counterparts and eclipse the liquidity offered on London’s ailing bourse.
In an address to parliament in Berl... |
| Oct 10, 2025 | Everest Medicines Names Fosun Pharma's Ex-Chair to Steer Launch of Its First Personalized Cancer Jab | (Yicai) Oct. 10 -- The former chairman of Chinese pharmaceutical giant Shanghai Fosun Pharmaceutical has been appointed chairman of the board at Everest Medicines as the innovative drugmaker prepares to bring its first personalized cancer v... |
| Sep 30, 2025 | Drug made from marijuana reduced back pain in large study | Please subscribe to IBJ to decode this article.
uminex hgira np sop.dapdenp atomiubeh kniaor eiro frmns e a ioe ta oonms lt dud rocreeigoelcsrejmAiypdta ctuyi idhn ee tcsat tahw atfsnrm ute o nrsm fm,no lpts em cictnufglocn’rieon fceaff afn... |
| Sep 26, 2025 | From Lagos to Munich: 5 acquisitions and 1 exit – African startups expanding into Europe | I have dedicated my work to building bridges between continents, connecting ecosystems, creating opportunities for exchange, and developing new business ties between startups across Africa and Europe.
We cannot deny that, compared to Europe... |
| Sep 19, 2025 | RFK Jr.’s vaccine panel weakens Covid shot recommendations, calling it an individual decision | Health and Human Services Secretary Robert F. Kennedy Jr.’s hand-picked vaccine panel weakened Covid shot recommendations in the U.S., advising that all Americans consult a health-care provider before deciding whether to receive the vaccine... |
| Aug 28, 2025 | US FDA narrows COVID-19 vaccine eligibility for under-65s, keeps full access for seniors | WASHINGTON: The US Food and Drug Administration (FDA) on Wednesday (Aug 27) approved updated COVID-19 vaccines for everyone aged 65 and over but narrowed access for younger people to those with health risks, a shift from previous years when... |
| Aug 27, 2025 | AI for Good in Africa: Promise or digital dependence? | Artificial Intelligence (AI) is fast becoming the world’s most transformative technology. From diagnosing diseases to predicting climate shocks, its potential to solve real-world problems is immense. Across Africa, global tech giants are ru... |
| Aug 12, 2025 | Sorting out COVID vaccine confusion: New and conflicting federal policies raise questions | With so much in flux, it’s important to check with your employer or insurer about coverage policies before you roll up your sleeve.
Here’s what we know so far, and what remains unclear.
Q: How have the recommendations changed?
What used to ... |
| Aug 10, 2025 | West Africa: AI in West Africa - Sober Audit of Current Landscape | A Nigerian startup, Ubenwa Health, is using AI to analyse baby cries for birth asphyxia detection with 96 per cent accuracy
The conversation on Artificial Intelligence in Africa largely falls into two camps. One faction believes the contine... |
| Aug 5, 2025 | Pfizer raises 2025 profit forecast as cost-cutting program gains traction | Pfizer raises 2025 profit forecast as cost-cutting program gains traction
By Bhanvi Satija and Michael ErmanAugust 5, 20254:40 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
SummaryCompanies
Qu... |
| Aug 1, 2025 | Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win | Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win
By ReutersAugust 1, 202510:19 AM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
A healthcare worker places vials... |
| Jul 31, 2025 | Pandemic darlings Moderna, BioNTech are now on two different paths | Covid-19 vaccine makers Moderna and BioNTech became household names almost overnight.
Moderna and BioNTech have spent their Covid vaccine windfalls differently, with Moderna investing in its own mRNA technology and BioNTech pursuing deals t... |
| Jul 25, 2025 | A €520 billion opportunity: New report makes the case for investors and policymakers to back EU-funded startups | A quiet revolution has been unfolding in Europe’s innovation ecosystem. EU-funded startups – particularly in critical sectors like deeptech, climatetech, AI, biotech and space – have quietly amassed over €520 billion in enterprise value. An... |
| Jul 17, 2025 | Sino Biopharm to Buy Out LaNova for Up to USD951 Million, Heralding Potential M&A Wave | (Yicai) July 17 -- Sino Biopharmaceutical said it plans to spend as much as USD951 million to fully acquire LaNova Medicines, a move that may point to more mergers and acquisitions in the Chinese drugs industry.
Sino Biopharm will buy the 9... |
| Jul 10, 2025 | Made in the MENA Region: How Local Innovation is Going Global "Made in MENA" no longer suggests a localized copy of something else. It's becoming a mark of originality for products built for real needs in tough markets, with potential for expansion designed from day one. | The most exciting new tech no longer needs to come from Silicon Valley. Across the Middle East and North Africa, startups are building smart, scalable solutions to urgent problems, gaining the attention of investors and global partners alik... |
| Jul 4, 2025 | Araris-Team sichert sich den mit 100‘000 Euro dotierten Strüngmann Award |
Das Gründerteam von Araris Biotech kann auf eine der erfolgreichsten Biotech-Firmengründungen der Schweiz in den vergangenen Jahren zurückblicken. Das 2019 aus dem Paul-Scherrer-Institut gegründete Spin-off hat eine proprietäre Linker-Payl... |
| Jul 4, 2025 | Everest Medicines targets global expansion with proprietary, AI-driven mRNA platform | After years of building a robust commercial base through in-licensing, Hong Kong-listed biopharmaceutical firm Everest Medicines is entering a new phase of growth: one defined by a “dual-engine” strategy that blends in-house innovation with... |
| Mar 5, 2025 | New report shows that EU startup funding has created massive economic impact valued over €500 billion | A first-of-its-kind report compiled by Dealroom, with Dealflow.eu and EU-Startups, reveals that a €12 billion investment made up of EU grants and Framework Programmes such as Horizon, has helped generate €520 billion in total company value.... |
| Mar 12, 2024 | Bion Applies for OMRI Listing for Commercial 10-0-0 Nitrogen Fertilizer | |
| Jan 8, 2024 | Africa: Technology Transfer Critical to Revolutionizing Africa's Pharma Industry | Kigali — An agreement signed between the Rwandan government and the Africa Pharmaceutical Technology Foundation (APTF) gives impetus to Africa's domestic industry with the hope of helping the continent tackle vaccine inequity and fill ... |
| Nov 6, 2023 | Biotheus Enters Into Strategic Partnership with BioNTech to Develop and Commercialize Bispecific Antibody Candidate Targeting PD-L1 and VEGF in Multiple Solid Tumor Indications | Bispecific Antibody Candidate PM8002 demonstrated encouraging data at this year's ASCO Annual Meeting (abstract #2536 & #e13091) and ESMO Congress (abstract #1992P)
BioNTech will hold exclusive licenses to develop and commercialize... |
| Aug 7, 2023 | DualityBio Expands Global Strategic Partnership with BioNTech to Accelerate Development of a Third Antibody-Drug Conjugate Therapeutics for Solid Tumors | SHANGHAI, Aug. 7, 2023 /PRNewswire/ -- Duality Biologics (Suzhou) Co. Ltd. ("DualityBio"), a clinical-stage biotech company focusing on the discovery and development of next generation antibody-drug conjugate ("ADC") the... |
| Aug 2, 2023 | Daily AI Roundup: Biggest Machine Learning, Robotic And Automation Updates 2nd August 2023 | This is our AI Daily Roundup . We are covering the top updates from around the world. The updates will feature state-of-the-art capabilities in artificial intelligence (AI), Machine Learning, Robotic Process Automation, Fintech, and human-s... |
| Aug 1, 2023 | BioNTech Completes Acquisition of InstaDeep | Acquisition aims to strengthen BioNTech’s pioneering position in the field of AI-powered drug discovery, design and development
InstaDeep to operate as London based subsidiary of BioNTech and will be the centerpiece of its growing portfolio... |
| May 29, 2023 | Life-science consultancy Advice Connect Inspire, LLC reaches €500M raised by portfolio companies | Advise Connect Inspire, LLC mentors and supports startups working on revolutionary solutions to improve global health through its flagship program, Gold Track.
Through Gold Track, startups gained access to invaluable mentorship, funding, an... |
| Jan 16, 2023 | Weekly Economic Index: Competition for Safaricom, salary increase in Ghana, and a gloomy future for SSA | Competition for Safaricom in Kenya
For years, mobile network provider, Safaricom, has dominated the telecoms market in East Africa’s most technologically advanced country, Kenya. Now, it has not one but two new viable competitors entering t... |
| Jan 11, 2023 | BioNTech to Acquire InstaDeep, for Approx. £362M | BioNTech SE (Nasdaq: BNTX), a Mainz, Germany-based immunotherapy company, acquired InstaDeep Ltd., a London, Uk-based technology company in the field of artificial intelligence and machine learning.
The transaction includes a total upfront ... |
| Jan 10, 2023 | BioNTech to acquire Instadeep in £562 million deal | BioNTech has announced a planned acquisition of London-based InstaDeep in a deal that will see £362 million in cash and BioNTech shares, excluding the shares already owned by BioNTech with InstaDeep shareholders eligible to receive addition... |
| Jan 10, 2023 | BioNTech to Acquire InstaDeep to Strengthen Pioneering Position in the Field of AI-powered Drug Discovery, Design and Development | BioNTech SE announced that they have entered into an agreement under which BioNTech will acquire InstaDeep, a leading global technology company in the field of artificial intelligence (“AI”) and machine learning (“ML”). The transaction incl... |
| Nov 21, 2022 | mRNA revolutionized the race for a Covid-19 vaccine. Could cancer be next? | This story has been adapted from the STAT Report “The future of messenger RNA: Covid-19 vaccines are just the beginning.”
The unprecedented success of messenger RNA vaccines against the coronavirus is raising hopes that the technology could... |
